Breadcrumb

Aleksandra Michalowska, PhD, MSc

Aleksandra Michalowska, PhD, MSc

  • Center for Cancer Research
  • National Cancer Institute
Associate Scientist

RESEARCH SUMMARY

Dr. Michalowska is a bioinformatics scientist specializing in computational and statistical approaches for preclinical cancer research. Her work integrates multi-omics data, including single-cell and spatial transcriptomics, to elucidate molecular mechanisms driving cancer progression and therapeutic response. She develops analytical frameworks to interpret large-scale transcriptional signatures from patient samples and experimental models while designing scalable workflows for next-generation sequencing and multimodal data integration, facilitating the discovery of predictive biomarkers and advancing precision oncology. Moreover, she specializes in high-throughput drug screening, utilizing advanced screening platforms and analytical methods to optimize both single-agent and combination treatment strategies for cancer therapy development.

Areas of Expertise

Preclinical cancer research
Drug screening
Statistical modeling
Bioinformatics

Publications

Selected Recent Publications

Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics.

Morse DB, Michalowski AM, Ceribelli M, De Jonghe J, Vias M, Riley D, Davies-Hill T, Voss T, Pittaluga S, Muus C, Liu J, Boyle S, Weitz DA, Brenton JD,Buenrostro JD, Knowles TPJ, Thomas CJ.
Cell Systems. 14(6): 464, 2023.
Full-Text Article
[ Journal Article ]

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma.

Peat TJ, Gaikwad SM, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, PhyoZ, Andres M, Hughitt VK, Simpson RM, Miller MA, Girvin AT, Taylor A, Williams D, D'Antonio N, Zhang Y, Rajagopalan A, Flietner E, Wilson K, Zhang X, Shinn P, Klumpp-Thomas C, McKnight C, Itkin Z, Chen L, Kazandijian D, Zhang J, Michalowski AM, Simmons JK, Keats J, Thomas CJ, Mock BA.
Cancer Letters. 568: 2023.
Full-Text Article
[ Journal Article ]

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.

Pérez-Guijarro E, Yang HH, Araya RE, El Meskini R, Michael HT, Vodnala SK, Marie KL, Smith C, Chin S, Lam KC, Thorkelsson A, Iacovelli AJ, Kulaga A, Fon A, Michalowski AM, Hugo W, Lo RS, Restifo NP, Sharan SK, Van Dyke T, Goldszmid RS, Weaver Ohler Z, Lee MP, Day CP, Merlino G.
Nature Medicine. 27(2): 355, 2021.
Full-Text Article
[ Journal Article ]

A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma.

Gaikwad SM, Phyo Z, Arteaga AQ, Gorjifard S, Calabrese DR, Connors D, HuangJ, Michalowski AM, Zhang S, Liu ZG, Schneekloth JS Jr, Mock BA.
Cancers (Basel). 12(10): 2952, 2020.
Full-Text Article
[ Journal Article ]

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.

Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S, Qin EY, Zhang X, Lennon J, Nagaraja S, Morris PJ, Quezada M, Gillespie SM, Duveau DY, Michalowski AM, Shinn P, Guha R, Ferrer M, Klumpp-Thomas C, Michael S, McKnight C, Minhas P, Itkin Z, Raabe EH, Chen L, Ghanem R, Geraghty AC, Ni L, Andreasson KI, Vitanza NA, Warren KE, Thomas CJ, Monje M.
Science Translational Medicine. 11(519): 2019.
Full-Text Article
[ Journal Article ]